Request for Covid-19 Impact Assessment of this Report

Medical Devices

Atrial Fibrillation Market by Devices (Surgical Devices [Maze Surgery and Catheter Ablation] and Non-Surgical Devices [Electric Cardioversion, Diagnostic Catheters, Mapping and Recording Systems, Cardiac Monitors, Access Devices, Left Atrial Appendage and Closure Devices, and Intracardiac Echocardiography Systems]) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL779162
  • 138 Pages
  • November 2016
  • Medical Devices
Download Sample    Get Discount   
 

Atrial fibrillation is of the most frequently occurred arrhythmia that causes problem with the rhythm of the heart (such as too slow or too fast heart beat). During atrial fibrillation, heart beats are irregular and it can be too slow or too fast as compared to the regular heartbeat. Atrial fibrillation can increase the rate of heart stroke, cause chest pain or even heart attack especially if the heart beat is too fast. During atrial fibrillation, both the chambers (upper and lower) beat irregularly, chaotically, and out of coordination of the heart. Shortness of breath, weakness, chest pain, dizziness, lightheadedness or fainting and heart palpitation are the common symptoms of atrial fibrillation. In addition, atrial fibrillation may lead to formation of blood clots in the heart, which may circulate to other organs. In atrial fibrillation, for altering the electrical system of heart, treatments such as medications and interventions are provided.

Atrial fibrillation market is in its emerging state as the prevalence of atrial fibrillation is growing rapidly along with the increase in aging population. According to American Heart Association, 33.5 million individuals (0.5% of the world’s population) were with atrial fibrillation in 2013. Also, technological advancement towards surgical devices for atrial fibrillation fuels the market growth. However, pitfalls such as stringent government policies, high cost of atrial fibrillation treatment, and dearth of skilled professionals and technicians hinders the market growth.

The world atrial fibrillation market has been segmented based on devices and region. Based on devices, the market is segmented into surgical devices and non-surgical devices. Surgical devices are further sub-classified into maze surgery and catheter ablation. Non-surgical devices are further sub-divided into electric cardioversion, diagnostic catheters, mapping and recording systems, cardiac monitors, access devices, left atrial appendage, and closure devices and intracardiac echocardiography (ICE) Systems. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

The key strategies adopted are product launch, collaboration, and merger & acquisition. For instance, Abbott acquired Kalila Medical, Inc. (U.S.), which helped Abbott develop next generation technologies that are useful to treat cardiac disorders such as atrial fibrillation. Biosense Webster, Inc. acquired Coherex Medical, Inc. (U.S.), which helped Biosense Webster, Inc. to strengthen its medical devices product portfolio.

KEY MARKET BENEFITS:

  • In-depth analysis of the market is conducted based on market estimations of the key segments for the period 2014-2022
  • Comprehensive analysis of factors that drive and restrict the growth of the world atrial fibrillation market is provided in the report
  • Exhaustive analysis of the world atrial fibrillation market by different segments helps understand the different aspects of atrial fibrillation that are currently used along with the variants that would gain prominence in the future
  • Competitive intelligence of leading manufacturers and distributors of atrial fibrillation market interprets the competitive scenario across various geographies
  • Key market players within the atrial fibrillation market are profiled in the report and their strategies are analyzed thoroughly, which predicts competitive outlook of the world market.

KEY MARKET SEGMENT:

By Devices

  • Surgical Devices

    • Maze Surgery
    • Catheter Ablation

      • Radiofrequency Catheter Ablation

        • Conventional RF Ablation Catheters
        • Irrigated-tip RF Ablation Catheters

      • Cryoablation
      • Microwave Based Catheter Ablation
      • Laser Based Catheter Ablation
      • Navigational Advanced Mapping Accessories

  • Non-Surgical Devices

    • Electric Cardioversion
    • Diagnostic Catheters

      • Conventional Diagnostic Catheters

        • Fixed Diagnostic Catheters
        • Steerable Diagnostic Catheters

      • Advanced Diagnostic Catheters

    • Mapping and Recording Systems
    • Cardiac Monitors
    • Access Devices
    • Left Atrial Appendage and Closure Devices
    • Intracardiac Echocardiography (ICE) Systems

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest of Asia-Pacific

  • LAMEA

    • Brazil
    • Argentina
    • Egypt
    • Israel
    • South Africa
    • Rest of LAMEA

KEY PLAYERS

  • Abbott Laboratories
  • Johnson & Johnson
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • St. Jude Medical, Inc.
  • Medtronic plc
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Siemens AG
  • AtriCure Inc.

Other players in the value chain include

  • Biosense Webster, Inc.
  • CardioFocus, Inc.
  • CathEffects Inc.
  • CathRx Ltd.
  • EndoPhotonix, Inc.
  • Japan Lifeline Co.
  • Osypka AG
  • Pioneer Medical Devices AG
  • GE Healthcare
  • TZ Medical, Inc.

*Profiles of these players are not included. The same will be included on request.

CHAPTER 1. INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. TOP WINNING STRATEGIES

3.4. PORTERS FIVE FORCES ANALYSIS

3.4.1. Bargaining power of suppliers

3.4.2. Bargaining power of buyers

3.4.3. Threat of new entrants

3.4.4. Competitive rivalry

3.4.5. Threat of substitutes

3.5. MARKET SHARE ANALYSIS, 2015

3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising prevalence of atrial fibrillation in geriatric population

3.6.1.2. Technological advancements

3.6.1.3. Increasing preference of catheter ablation for cardiac arrhythmia treatment

3.6.2. Restraints

3.6.2.1. Dearth of skilled professionals

3.6.2.2. Unfavorable preference to pharmaceutical interventions (drugs) over AF treatment devices

3.6.3. Opportunities

3.6.3.1. Rising awareness of atrial fibrillation

3.6.3.2. Opportunities in emerging countries

CHAPTER 4. ATRIAL FIBRILLATION MARKET, BY DEVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SURGICAL DEVICES

4.2.1.1. Key market trends

4.2.1.2. Key growth factors and opportunities

4.2.2. Market size and forecast

4.2.2.1. MAZE surgery

4.2.2.2.Catheter ablation

4.3. NON-SURGICAL DEVICES

4.3.1. Key market trends

4.3.1.2. Key growth factors and opportunities

4.3.2. Market size and forecast

4.3.2.1. Electric cardioversion

4.3.2.2. Mapping and recording systems

4.3.2.3. Cardiac monitors

4.3.2.4. Access devices

4.3.2.5. Left Atrial Appendage (LAA) and closure devices

4.3.2.6. Intracardiac echocardiography (ICE) systems

CHAPTER 5. ATRIAL FIBRILLATION MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends

5.2.2. Key growth factors and opportunities

5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast

5.2.3.2. Canada market size and forecast

5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends

5.3.2. Key growth factors and opportunities

5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast

5.3.3.2. France market size and forecast

5.3.3.3. U.K. market size and forecast

5.3.3.4. Italy market size and forecast

5.3.3.5. Spain market size and forecast

5.3.3.6. Rest of Europe market size and forecast

5.4. ASIA PACIFIC

5.4.1. Key market trends

5.4.2. Key growth factors and opportunities

5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast

5.4.3.2. India market size and forecast

5.4.3.3. China market size and forecast

5.4.3.4. Australia market size and forecast

5.4.3.5. South Korea market size and forecast

5.4.3.6. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends

5.5.2. Key growth factors and opportunities

5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast

5.5.3.2. Argentina market size and forecast

5.5.3.3. Egypt market size and forecast

5.5.3.4. Israel market size and forecast

5.5.3.5. South Africa market size and forecast

5.5.3.6. Rest of LAMEA market size and forecast

CHAPTER 6. COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview

6.1.2. Company snapshot

6.1.3. Operating business segments

6.1.4. Business performance

6.1.5. Key strategic moves & developments

6.2. JOHNSON & JOHNSON

6.2.1. Company overview

6.2.2. Company snapshot

6.2.3. Operating business segments

6.2.4. Business performance

6.2.5. Key strategic moves & developments

6.3. ATRICURE, INC.

6.3.1. Company overview

6.3.2. Company snapshot

6.3.3. Operating business segments

6.3.4. Business performance

6.3.5. Key strategic moves & developments

6.4. MICROPORT SCIENTIFIC CORPORATION

6.4.1. Company overview

6.4.2. Company Snapshot

6.4.3. Operating Business Segments

6.4.4. Business Performance

6.4.5. Key strategic moves & developments

6.5. BOSTON SCIENTIFIC CORPORATION

6.5.1. Company overview

6.5.2. Operating business segments

6.5.3. Business performance

6.5.4. Key strategic moves & developments

6.6. ST. JUDE MEDICAL, INC.

6.6.1. Company overview

6.6.2. Operating business segments

6.6.3. Business performance

6.6.4. Key strategic moves & developments

6.7. MEDTRONIC PLC

6.7.1. Company overview

6.7.2. Operating business segments

6.7.3. Business performance

6.7.4. Key strategic moves & developments

6.8. BIOTRONIK SE & CO. KG

6.8.1. Company overview

6.8.2. Operating business segments

6.8.3. Key strategic moves & developments

6.9. KONINKLIJKE PHILIPS N.V.

6.9.1. Company overview

6.9.2. Philips- SNAPSHOT

6.9.3. Operating business segments

6.9.4. Business performance

6.9.5. Key strategic moves and developments

6.10. SIEMENS AG

6.10.1. Company overview

6.10.2. Siemens Healthcare- SNAPSHOT

6.10.3. Operating business segments

6.10.4. Financial performance

6.10.5. Key strategic moves and developments

List of Tables

TABLE 1. WORLD ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022

TABLE 2. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY DEVICES TYPE ($MILLION), 2014-2022

TABLE 3. WORLD SURGICAL DEVICES ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022

TABLE 4. WORLD ATRIAL FIBRILLATION MARKET FOR CATHETER ABLATION ($MILLION), 2014-2022

TABLE 5. WORLD ATRIAL FIBRILLATION MARKET FOR RADIOFREQUENCY CATHETER ABLATION($MILLION), 2014-2022

TABLE 6. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY TYPE ($MILLION), 2014-2022

TABLE 7. WORLD ATRIAL FIBRILLATION MARKET FOR NON-SURGICAL DEVICES, BY REGION ($MILLION), 2014-2022

TABLE 8. WORLD ATRIAL FIBRILLATION MARKET FOR DIAGNOSTIC CATHETER ($MILLION), 2014-2022

TABLE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL DIAGNOSTIC CATHETER ($MILLION), 2014-2022

TABLE 10. WORLD ATRIAL FIBRILLATION MARKET, BY REGION ($MILLION), 2014-2022

TABLE 11. NORTH AMERICA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

TABLE 12. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022

TABLE 13. EUROPE ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

TABLE 14. EUROPE ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022

TABLE 15. ASIA PACIFIC ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

TABLE 16. ASIA PACIFIC ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022

TABLE 17. LAMEA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

TABLE 18. LAMEA ATRIAL FIBRILLATION MARKET, BY DEVICES ($MILLION), 2014-2022

TABLE 19. ABBOTT: COMPANY SNAPSHOT

TABLE 20. ABBOTT: OPERATING SEGMENTS

TABLE 21. J&J: COMPANY SNAPSHOT

TABLE 22. J&J: OPERATING SEGMENTS

TABLE 23. ATRICURE, INC.: COMPANY SNAPSHOT

TABLE 24. ATRICURE: OPERATING SEGMENTS

TABLE 25. MICROPORT: COMPANY SNAPSHOT

TABLE 26. MICROPORT: OPERATING SEGMENTS

TABLE 27. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 28. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 29. ST. JUDE MEDICAL: COMPANY SNAPSHOT

TABLE 30. ST. JUDE MEDICAL: OPERATING SEGMENTS

TABLE 31. MEDTRONIC: COMPANY SNAPSHOT

List of Figures

FIGURE 1. ATRIAL FIBRILLATION MARKET SEGMENTATION

FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2012 - 2016)

FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE

FIGURE 4. PORTERS FIVE FORCES ANALYSIS

FIGURE 5. MARKET SHARE ANALYSIS, 2015

FIGURE 6. TOP IMPACTING FACTORS: WORLD ATRIAL FIBRILLATION MARKET

FIGURE 7. PREVALENCE OF ATRIAL FIBRILLATION BY AGE, 2012

FIGURE 8. WORLD ATRIAL FIBRILLATION MARKET FOR MAZE SURGERY ($MILLION), 2014-2022

FIGURE 9. WORLD ATRIAL FIBRILLATION MARKET FOR CRYOABLATION ($MILLION), 2014-2022

FIGURE 10. WORLD ATRIAL FIBRILLATION MARKET FOR MICROWAVE BASED CATHETER ABLATION ($MILLION), 2014-2022

FIGURE 11. WORLD ATRIAL FIBRILLATION MARKET FOR LASER BASED CATHETER ABLATION ($MILLION), 2014-2022

FIGURE 12. WORLD ATRIAL FIBRILLATION MARKET FOR NAVIGATIONAL ADVANCED MAPPING ACCESSORIES ($MILLION), 2014-2022

FIGURE 13. WORLD ATRIAL FIBRILLATION MARKET FOR CONVENTIONAL RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022

FIGURE 14. WORLD ATRIAL FIBRILLATION MARKET FOR IRRIGATED-TIP RADIOFREQUENCY CATHETER ABLATION ($MILLION), 2014-2022

FIGURE 15. WORLD ATRIAL FIBRILLATION FOR ELECTRIC CARDIOVERSION ($MILLION), 2014-2022

FIGURE 16. WORLD ATRIAL FIBRILLATION MARKET FOR FIXED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022

FIGURE 17. WORLD ATRIAL FIBRILLATION MARKET FOR STEERABLE DIAGNOSTIC CATHETERS ($MILLION), 2014-2022

FIGURE 18. WORLD ATRIAL FIBRILLATION MARKET FOR ADVANCED DIAGNOSTIC CATHETERS ($MILLION), 2014-2022

FIGURE 19. WORLD ATRIAL FIBRILLATION MARKET FOR MAPPING AND RECORDING SYSTEMS ($MILLION), 2014-2022

FIGURE 20. WORLD ATRIAL FIBRILLATION MARKET FOR CARDIAC MONITORS ($MILLION), 2014-2022

FIGURE 21. WORLD ATRIAL FIBRILLATION MARKET FOR ACCESS DEVICES ($MILLION), 2014-2022

FIGURE 22. WORLD ATRIAL FIBRILLATION MARKET FOR LEFT ATRIAL APPENDAGE AND CLOSURE DEVICES ($MILLION), 2014-2022

FIGURE 23. WORLD ATRIAL FIBRILLATION MARKET FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) SYSTEMS ($MILLION), 2014-2022

FIGURE 24. U.S. ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 25. CANADA ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 26. MEXICO ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 27. GERMANY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 28. FRANCE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 29. U.K.: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 30. ITALY: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 31. SPAIN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 32. REST OF EUROPE: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 33. JAPAN: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 34. INDIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 35. CHINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 36. AUSTRALIA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 37. SOUTH KOREA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 38. REST OF ASIA-PACIFIC: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 39. BRAZIL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022

FIGURE 40. ARGENTINA: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 41. EGYPT: ATRIAL FIBRILLATION MARKET ($MILLION), 2014-2022

FIGURE 42. ISRAEL: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022

FIGURE 43. SOUTH AFRICA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022

FIGURE 44. REST OF LAMEA: ATRIAL FIBRILLATION DEVICES MARKET ($MILLION), 2014-2022

FIGURE 45. ABBOTT: NET SALES ($MILLION), 2013-2015

FIGURE 46. ABBOTT: NET SALES, BY BUSINESS SEGMENT (%), 2015

FIGURE 47. J&J: NET SALES, BY BUSINESS SEGMENT (%), 2015

FIGURE 48. J&J: NET SALES, BY REGION (%), 2015

FIGURE 49. J&J: STRATEGY SHARE (%), 2014-2015

FIGURE 50. ATRICURE: NET SALES ($MILLION), 2013-2015

FIGURE 51. ATRICURE: NET SALES, BY BUSINESS SEGMENT (%), 2015

FIGURE 52. ATRICURE: NET SALES, BY REGION (%), 2015

FIGURE 53. ATRICURE: STRATEGY SHARE (%), 2013-2016

FIGURE 54. MICROPORT: NET SALES ($MILLION), 2013-2015

FIGURE 55. MICROPORT: NET SALES, BY PRINCIPAL PRODUCT CATEGORY (%), 2015

FIGURE 56. MICROPORT: NET SALES , BY REGION (%), 2015

FIGURE 57. MICROPORT: STRATEGY SHARE (%), 2013- 2015

FIGURE 58. BOSTON SCIENTIFIC: NET SALES ($MILLION), 2013-2015

FIGURE 59. BOSTON SCIENTIFIC: NET SALES, BY BUSINESS SEGMENT (%), 2015

FIGURE 60. BOSTON SCIENTIFIC: RHYTHM MANAGEMENT NET SALES, BY SUB-SEGMENT (%), 2015

FIGURE 61. BOSTON SCIENTIFIC: NET SALES, BY REGION (%), 2015

FIGURE 62. BOSTON SCIENTIFIC: STRATEGY SHARE (%), 2013-2016

FIGURE 63. ST. JUDE MEDICAL: NET SALES ($MILLION), 2013-2015

FIGURE 64. ST. JUDE MEDICAL: NET SALES, BY PRODUCT CATEGORY (%), 2015

FIGURE 65. ST. JUDE MEDICAL: NET SALES, BY REGION (%), 2015

FIGURE 66. ST. JUDE MEDICAL: STRATEGY SHARE (%), 2014-2016

FIGURE 67. MEDTRONIC: OPERATING SEGMENTS

FIGURE 68. MEDTRONIC: NET SALES ($MILLION), 2014-2016

FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT (%), 2016

FIGURE 70. MEDTRONIC: CARDIAC AND VASCULAR GROUP NET SALES, BY SUB-SEGMENT (%), 2016

FIGURE 71. MEDTRONIC: NET SALES, BY REGION (%), 2016

FIGURE 72. MEDTRONIC: STRATEGY SHARE (%), 2014- 2016

FIGURE 73. BIOTRONIK: COMPANY SNAPSHOT

FIGURE 74. BIOTRONIK: OPERATING SEGMENTS

FIGURE 75. BIOTRONIK: STRATEGY SHARE (%), 2013-2016

FIGURE 76. PHILIPS: COMPANY SNAPSHOT

FIGURE 77. PHILIPS- OPERATING SEGMENTS

FIGURE 78. PHILIPS-NET SALES ($MILLION), 2013-2015

FIGURE 79. PHILIPS- NET SALES, BY SEGMENT (%), 2015

FIGURE 80. PHILIPS- NET SALES, BY REGION (%), 2015

FIGURE 81. PHILLIPS- STRATEGY SHARE (%), 2015-2016

FIGURE 82. SIEMENS-COMPANY SNAPSHOT

FIGURE 83. SIEMENS: OPERATING SEGMENTS

FIGURE 84. SEIMENS: NET SALES ($MILLION), 2013-2015

FIGURE 85. SEIMENS: NET SALES, BY SEGMENT (%), 2015

FIGURE 86. SEIMENS- NET SALES, BY REGION (%), 2015

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370